China is forging ahead to conduct human clinical trials of treatments using the CRISPR gene-editing tool, the Wall Street Journal reports. The first CRISPR trial began in China in 2015, while the first outside of China, likely to be at the University of Pennsylvania, has yet to begin, it adds.
Already have a GenomeWeb or 360Dx account?Login Now.
What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.
A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.
Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.
In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.